T Cell Costimulation Blockade with CTLA4-Ig (Abatacept) for Acute Gvhd Prevention in HLA Matched and Mismatched Unrelated Donor Transplantation: Results of the First Phase 2 Trial

Ben Watkins(Emory University), Leslie S. Kean(Boston Children's Hospital), Brandi Bratrude(Boston Children's Hospital), Kayla Cribbin(Seattle Children's Hospital), Catherine Bresee(Cedars-Sinai Medical Center), Naomi Schwartz, Kayla Betz(Boston Children's Hospital), Andrew C. Harris(Primary Children's Hospital), Mourad Tighiouart(Cedars-Sinai Medical Center), Michael Grimley(Cincinnati Children's Hospital Medical Center), Alexandria Narayan(Fred Hutch Cancer Center), Muna Qayed(Emory University), Alison Yu(Boston Children's Hospital), Shauna Sinclair(Seattle Children's Hospital), Roger Giller(Center for Cancer and Blood Disorders), Amelia Langston(CancerCare Manitoba), Anglea Banks(Cedars-Sinai Medical Center), Chrstine Duncan(Dana-Farber Cancer Institute), James Rhodes(Aflac (United States)), Bruce R. Blazar(University of Minnesota Medical Center), John Horan(Emory University), Sung Won Choi(University of Michigan), Yvonne Suessmuth(Emory University), Kirk R. Schultz(University of British Columbia), David A. Jacobsohn(Children's National), Kyle Hebert(Harvard University), Daniel J. Hunt(Seattle Children's Hospital), Nahal Lalefar(University of California, San Francisco), Marcelo C. Pasquini(Cleveland Clinic), Scott Gillespie(Emory University), André Rogatko(Cedars-Sinai Medical Center), Sungjin Kim(Cedars-Sinai Medical Center), Aleksandra Petrović(Seattle Children's Hospital), Carol Dean, Shalini Shenoy(Washington University in St. Louis), Michael A. Pulsipher(Primary Children's Hospital), Jeffrey H. Davis(BC Children's Hospital), Maxim Norkin(Centre Hospitalier Universitaire Vaudois)
Transplantation and Cellular Therapy
January 31, 2019
Cited by 11


Related Papers